Back to Screener

Talkspace, Inc. Common Stock (TALK)

Price$5.17

Favorite Metrics

Price vs S&P 500 (26W)79.35%
Price vs S&P 500 (4W)-5.04%
Market Capitalization$863.78M
P/E Ratio (Annual)110.84x

All Metrics

P/CF (Annual)101.22x
Book Value / Share (Quarterly)$0.70
P/TBV (Annual)5.31x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)24.15%
Cash Flow / Share (Quarterly)$-0.01
Price vs S&P 500 (YTD)39.78%
Gross Margin (TTM)42.92%
Net Profit Margin (TTM)3.40%
EPS (TTM)$0.05
10-Day Avg Trading Volume2.07M
EPS Excl Extra (TTM)$0.05
Revenue Growth (5Y)24.60%
EPS (Annual)$0.04
ROI (Annual)6.66%
Gross Margin (Annual)42.97%
Net Profit Margin (5Y Avg)-26.11%
Cash / Share (Quarterly)$0.56
P/E Basic Excl Extra (TTM)110.84x
Revenue Growth QoQ (YoY)29.31%
P/E Normalized (Annual)110.84x
ROA (Last FY)5.78%
Revenue Growth TTM (YoY)22.00%
EBITD / Share (TTM)$0.04
ROE (5Y Avg)-20.73%
Operating Margin (TTM)1.38%
Cash Flow / Share (Annual)$-0.01
P/B Ratio7.38x
P/B Ratio (Quarterly)5.14x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)3.61x
Net Interest Coverage (TTM)-54.75x
ROA (TTM)5.87%
EPS Growth QoQ (YoY)352.46%
EV / EBITDA (TTM)136.76x
EPS Incl Extra (Annual)$0.04
Current Ratio (Annual)6.38x
Quick Ratio (Quarterly)6.38x
3-Month Avg Trading Volume3.24M
52-Week Price Return85.30%
P/E Incl Extra (TTM)110.84x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.69
P/S Ratio (Annual)3.77x
Asset Turnover (Annual)1.70x
52-Week High$5.20
Operating Margin (5Y Avg)-33.73%
EPS Excl Extra (Annual)$0.04
CapEx CAGR (5Y)58.31%
Tangible BV CAGR (5Y)73.49%
26-Week Price Return83.33%
Quick Ratio (Annual)6.38x
13-Week Price Return29.57%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)6.38x
Enterprise Value$826.431
Revenue / Share Growth (5Y)21.38%
Asset Turnover (TTM)1.72x
Book Value / Share Growth (5Y)53.86%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)3.66%
Cash / Share (Annual)$0.56
3-Month Return Std Dev58.31%
Gross Margin (5Y Avg)49.60%
Net Income / Employee (TTM)$0
ROE (Last FY)6.66%
Net Interest Coverage (Annual)-11.26x
EPS Basic Excl Extra (Annual)$0.04
P/FCF (TTM)217.30x
Receivables Turnover (TTM)17.81x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.05
Receivables Turnover (Annual)17.81x
ROI (TTM)6.89%
P/S Ratio (TTM)3.77x
Pretax Margin (5Y Avg)-25.97%
Revenue / Share (Annual)$1.32
Tangible BV / Share (Annual)$0.68
Forward P/E38.12x
Price vs S&P 500 (52W)55.47%
P/E Ratio (TTM)110.84x
EPS Growth TTM (YoY)737.04%
Year-to-Date Return42.42%
5-Day Price Return0.10%
EPS Normalized (Annual)$0.04
ROA (5Y Avg)-17.18%
Net Profit Margin (Annual)3.40%
Month-to-Date Return-0.10%
Cash Flow / Share (TTM)$-0.21
EBITD / Share (Annual)$0.03
Operating Margin (Annual)1.38%
P/CF (TTM)101.22x
ROI (5Y Avg)-20.73%
P/E Excl Extra (TTM)110.84x
EPS Basic Excl Extra (TTM)$0.05
P/TBV (Quarterly)3.63x
P/B Ratio (Annual)5.14x
Pretax Margin (TTM)3.66%
Book Value / Share (Annual)$0.70
Price vs S&P 500 (13W)28.89%
Beta1.13x
P/FCF (Annual)137.96x
Revenue / Share (TTM)$1.33
ROE (TTM)6.89%
52-Week Low$2.22

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.15
4.15
4.07
3.64

Industry Peers — Health Services(13)

SymbolP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
TALKTalkspace, Inc. Common Stock
110.84x22.00%1.38%6.89%$5.17
PRVAPrivia Health Group, Inc. Common Stock
126.50x22.26%1.61%3.29%$23.50
LFSTLifeStance Health Group, Inc. Common Stock
264.21x-12.76%2.07%0.65%$6.67
WGSGeneDx Holdings Corp. Class A Common Stock
39.97%-3.06%-7.41%$65.42
USPHUS Physical Therapy Inc
29.52x16.33%11.08%8.00%$78.18
INNVInnovAge Holding Corp. Common Stock
13.48%1.01%2.66%$8.37
PNTGThe Pennant Group, Inc. Common Stock
35.79x36.31%5.47%9.31%$30.42
OMDAOmada Health, Inc. Common Stock
-5.41%-7.10%$13.37
SRTAStrata Critical Medical, Inc. Class A Common Stock
9.45x-3.02%-10.18%16.45%$4.50
DCGODocGo Inc. Common Stock
3.28x-47.74%-56.81%-71.45%$0.58
PIIIP3 Health Partners Inc. Common Stock
-2.76%-18.53%-191.97%$2.50

About

Talkspace operates a telehealth platform connecting users with licensed therapists, psychologists, and psychiatrists. The company generates revenue through contracts with health plans, enterprises, and direct consumer subscriptions, typically lasting one to three years. Operations and revenue are concentrated in the United States.